Search Results for 'taf'

taf published presentations and documents on DocSlides.

Switching to Bictegravir

Switching to Bictegravir

by emery

/. Emtricitabine. /. Tenofovir. . Alafenamide. (...

In der vorliegenden Präsentation können Informationen zu Arzneimitteln von Janssen enthalten sein

In der vorliegenden Präsentation können Informationen zu Arzneimitteln von Janssen enthalten sein

by lam

Diese Präsentation dient ausschließlich der wiss...

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

by jacey

1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...

Gilead-initiated or Gilead-supported Abstracts Published at EACS 2023

Gilead-initiated or Gilead-supported Abstracts Published at EACS 2023

by hailey

Abstracts selected by Gilead Medical Affairs Germa...

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

by taylor

Supported by an educational grant from Gilead Scie...

Introduction Characteristics, Treatment Patterns,

Introduction Characteristics, Treatment Patterns,

by cappi

and . Virologic. Outcomes . for Treatment-experie...

CROI 2015: Treatment and Cure Highlights

CROI 2015: Treatment and Cure Highlights

by unita

Shireesha Dhanireddy. Robert Harrington. March 17,...

Any PRM at baseline Yes No

Any PRM at baseline Yes No

by lucy

39. 129. 100 . (91, 100). 98 . (95, 100). NRTI PRM...

Interactive ART Cases From the Clinic: Is There One Right Answer?

Interactive ART Cases From the Clinic: Is There One Right Answer?

by megan

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Brad Hare Nothing to Disclose

Brad Hare Nothing to Disclose

by beatrice

Kaiser Permanente San Francisco Medical Center. Sa...

Renal and Bone Safety of

Renal and Bone Safety of

by ashley

Tenofovir. . Alafenamide. . vs. . Tenofovir. ....

Weight change before and after switching therapy to

Weight change before and after switching therapy to

by ash

tenofovir. . alafenamide. (TAF) in virologically...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

by lam

Endpoints. Primary: proportion of patients with HI...

Developing the Early Years System in Cwm Taf

Developing the Early Years System in Cwm Taf

by ani

Representatives of the Cwm Taf Early Years Co-cons...

TSI TAF TAP: TCM PTCPM Gijs Prozee

TSI TAF TAP: TCM PTCPM Gijs Prozee

by bitsy

7 & 15 mei 2019. TSI TAF TAP: TCM PTCPM?. Een ...

Challenging Cases in Antiretroviral Therapy and Panel Discussion

Challenging Cases in Antiretroviral Therapy and Panel Discussion

by gagnon

Paul E. Sax, MD. Professor of Medicine. Harvard Me...

Paediatric ARV Drug Optimization 3 Review Summary report &

Paediatric ARV Drug Optimization 3 Review Summary report &

by neoiate

*\n\b...

WHO ARV Forecasting Meeting

WHO ARV Forecasting Meeting

by sistertive

Geneva, March 19 - 20 , 2015 1 | Treatment and C...

HIV Update Ardis Moe, M.D.

HIV Update Ardis Moe, M.D.

by nonhurmer

amoe@mednet.ucla.edu. UCLA CARE clinic/NEVHC Van N...

PrEP Cases Kevin L. Ard, MD, MPH Massachusetts General Hospital

PrEP Cases Kevin L. Ard, MD, MPH Massachusetts General Hospital

by alexa-scheidler

PrEP Cases Kevin L. Ard, MD, MPH Massachusetts Ge...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

by phoebe-click

ACTIVITY CODE . TD342. Antiretroviral Medications...

Treating HIV Infection: HIV/AIDS Treatment

Treating HIV Infection: HIV/AIDS Treatment

by celsa-spraggs

A Dynamic Field. SINGLE Study. Phase 3, Open-Labe...

Use the Web Browser on Your Mobile Device to Participate in Polling*

Use the Web Browser on Your Mobile Device to Participate in Polling*

by phoebe-click

Go to: pollev.com/CCO2. or scan the QR code below...

HIV 2015-2016: New Agents, New Strategies

HIV 2015-2016: New Agents, New Strategies

by ellena-manuel

Learning Objectives. EARLY VS DEFERRED ART. The C...

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

by cheryl-pisano

Esteban Burrone, . July 2017. THE MEDICINES PATEN...

Comprehensive Guideline Summary

Comprehensive Guideline Summary

by aaron

Guidelines for the Use of Antiretroviral Agents. ...

Multi Agency Safeguarding Hub

Multi Agency Safeguarding Hub

by phoebe-click

(MASH). Schedule for the Day. 9.30 – 10am. Regi...

DECLINED CASE TOPICS Taxpayers Against Fraud Education Fund Annual Conference

DECLINED CASE TOPICS Taxpayers Against Fraud Education Fund Annual Conference

by ellena-manuel

October 3, 2018. DECLINED CASE TOPICS: PANELISTS....

Cognitive explanation for OCD

Cognitive explanation for OCD

by pamella-moone

Recap. Case history. A 32-year-old man presents d...

Cognitive explanation for OCD

Cognitive explanation for OCD

by luanne-stotts

Recap. Case history. A 32-year-old man presents d...

OR P UB LIC AT ION TED STA TES C T O F A PPEA LS T N I

OR P UB LIC AT ION TED STA TES C T O F A PPEA LS T N I

by sherrill-nordquist

NTEG TY TAF NG OL UTI ONS NC Defendant Appellee ...

ti wimm WBf mm A P TH PBIKCETO UNION THURSDAY HA

ti wimm WBf mm A P TH PBIKCETO UNION THURSDAY HA

by phoebe-click

WP f i TH PRINCETO UNIO N B O DUNN Publishe ...

Aversive intrusive thoughts as contributors to inflated res

Aversive intrusive thoughts as contributors to inflated res

by karlyn-bohler

Graham C L Davey, Frances . Meeten. , Georgina Ba...

DISC SPRINGSF-TAF, DIN 2093Group 1 and Group 2 springsGroup 3 springs

DISC SPRINGSF-TAF, DIN 2093Group 1 and Group 2 springsGroup 3 springs

by phoebe-click

120 t tDe LoLo DeDi s Di 121 0,100,10,20,30,40,50,...

Technology Assessement Framework

Technology Assessement Framework

by jane-oiler

(TAF) for . Selected WASH Technologies in Ghana. ...

by lindy-dunigan

on horseback (Pegasus?) decapitates Medusa and e...

IAS – USA Fall New York Course: Case Discussion

IAS – USA Fall New York Course: Case Discussion

by jalin

Luke . Jerram. Disclosures: Educational grant supp...

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

Subjects with Renal Impairment Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety through 48 Weeks Study GS-US-292-0112

by micah

Tenofovir. . Disoproxil. . Fumarate. to . Tenof...

Safety of Tenofovir

Safety of Tenofovir

by deandre922

Alafenamide. in Renal Impairment. A Pozniak. 1. ,...

When and What To Start Melanie A. Thompson, MD

When and What To Start Melanie A. Thompson, MD

by paxton651

Thacker & Thompson, MD. Atlanta, Georgia. Fina...